GlaxoSmithKline accused of skewing debate on drug safety

Posted on the 19th March 2010

More than 90 per cent of scientists who backed a drug at the centre of a safety scare had financial links to the pharmaceutical industry, and 87 per cent had financial links with the drug's manufacturer, GlaxoSmithKline.

Avandia, which is prescribed to millions of people with type 2 diabetes, was linked with an increased risk of heart attacks in research published in 2007, and since then debate over whether it should be withdrawn has been ongoing.

Cases such as this renew concern about the influence of pharmaceutical companies on patient safety. The industry has been known to manipulate results and selectively withhold unfavourable data in order to get drugs approved, thereby putting people at risk of unpleasant – and potentially dangerous – side effects.

For more information on the harm done to people and animals by the pharmaceutical industry, read our report Making a Killing.

Read the article in "The Independent"

Read more posts...

We’ve won the Lush prize!

Weโ€™re absolutely delighted to announce that Animal Aid has been awarded the Public Awareness Lush Prize 2024 for our campaign to end lethal dose animal tests! We really could not be happier โ€“ this is...

Posted 21 May 2024

Animal Aid director Iain Green and Head of Campaigns Jessamy Korotoga holding a Lush prize statuette of a hare

Live Exports Ban: Does it go far enough?

Yesterday, we shared the news that the Animal Welfare (Livestock Exports) Bill has passed its final stage in Parliament and will soon be enshrined into law. But does it go far enough?

Posted 15 May 2024